Tryptophan-Kynurenine Pathway in COVID-19-Dependent Musculoskeletal Pathology: A Minireview
- Sagar Vyavahare,
- Sandeep Kumar,
- Nicholas Cantu,
- ,
- ,
- Augusta University,
- ,
- ,
- ,
- Medical University of South Carolina,
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOpen access
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), affecting multiple organ systems, including the respiratory tract and lungs. Several studies have reported that the tryptophan-kynurenine pathway is altered in COVID-19 patients. The tryptophan-kynurenine pathway plays a vital role in regulating inflammation, metabolism, immune responses, and musculoskeletal system biology. In this minireview, we surmise the effects of the kynurenine pathway in COVID-19 patients and how this pathway might impact muscle and bone biology.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Article number
2911578Journal (Volume, Issue Number)
Mediators of Inflammation (Volume 2021)Publication milestones
- Published - 2021
Publication status
Published - 2021
ISSN
0962-9351Publication IDs
- Scopus: 85117400203
- PubMed: 34621138
Publication metrics
Metrics
Fractional count
7
Fractional count
0.70
Fractional count
3
Fractional count
0.30
Fractional count
7
Fractional count
1
PlumX, opens in new tab
Captures
37
Social media
30
Citation count
19
Funding Details
FunderFunding number
NIA
P01AG036675
